NASA grant will allow the Center for Applied NanoBioscience and Medicine to study the health effects of long space missionsContinue reading
Author Archive: AZBio
Banner Alzheimer’s Institute, Novartis, and Amgen Expand Collaboration in Pioneering Alzheimer’s Prevention Program
Second study to probe whether an investigational drug can prevent or delay the emergence of symptoms in high-risk older adultsContinue reading
Announcing the 2017 AZBio Trailblazers
The 2017 AZBio Trailblazer Honorees are: House Speaker JD Mesnard, Senator Nancy Barto, Senator Kimberly Yee, Senator Kate Brophy McGee, Representative Lela Alston, Representative Heather Carter, Representative Regina Cobb, DDS, Representative Randall Friese, MD, and Representative Jay Lawrence.Continue reading
Nine Life Science Companies Make The Top 5 in the Fall 2017 Arizona Innovation Challenge Finals
The Arizona Commerce Authority has announced the 25 semifinalists in the Fall 2017 round of the Arizona Innovation Challenge. The semifinalists include: Breezing Co. (Tempe), GT Medical Technologies (Gilbert), Life365 Inc. (Tempe), Merchant’s Garden AgroTech Inc. (Tucson), MicronView LLC (Tucson), NanoPin Technologies Inc. (Phoenix), Resonea (Scottsdale), SkinSafe Inc. (Scottsdale), and VB Cosmetics Inc. (Chandler).Continue reading
Munk appointed deputy director of ASU’s Biodesign Institute
Stephen Munk has joined the Biodesign Institute at Arizona State University as deputy director of science and technology. In this role, Munk will focus on the strategic, business and technical operations of Arizona’s single largest bioscience research infrastructure investment.Continue reading
UA Cancer Center Research Team Explores Anti-Breast Cancer Properties of Soy
A University of Arizona Cancer Center and College of Agriculture and Life Sciences research team is engaged in a series of studies to investigate how genistein, a component of soy foods, might suppress the development of breast cancer.Continue reading
Startup Regulonix Licenses University of Arizona Non-opioid Pain Drug Candidates
Tucson, Ariz. – Researchers in the University of Arizona College of Medicine – Tucson have invented a new class of non-opioid compounds to treat pain. Animal testing has shown that the drug candidates are more effective than morphine, non-addictive, and non-toxic at high doses. The UA has licensed the compounds to startup Regulonix. Continue reading
Startup Licenses University of Arizona Technology That Shortens Cancer Cell Life
The University of Arizona has licensed a drug that aims to shorten the lives of cancer cells to startup Reglagene. The technology, invented at the UA College of Pharmacy and the UA BIO5 Institute by Laurence Hurley, PhD, and Vijay Gokhale, PhD, has been shown to be effective in shortening the lives of target cells, essentially inducing cancer cells to grow old and die.Continue reading
Young Entrepreneurs Receive FDA Clearance for Medical Device Poised to Disrupt Newborn Care Market
Through its empathy-driven innovation model, NeoLight develops technologies that treat infants with life threatening medical conditions.